Eamonn Molloy, M.D.
| Appointed: |
2008 |
| Gender: |
Male |
| Languages: |
English |
Rheumatologic and Immunologic Disease
Biographical Sketch
Other publications:
- Molloy E, Ramakrishnan S, Murphy E, Barry M. Morbidity and mortality in rheumatoid patients during treatment with adalimumab and infliximab. Rheumatology 2004; 43: 522-3.
- Molloy E, Cahill M, O?Hare JA. Cerebral venous sinus thrombosis precipitated by Graves? disease and factor V Leiden mutation. Ir Med J 2003; 96(2): 46-7.
- Molloy E, O?Hare JA. Unraveling medical outpatient referrals. Ir Med J 2003; 96(5): 145-6.
- Molloy E, Clarke D, Fearon U, Cunningham SK, McKenna TJ. Non-ACTH pro-opiomelanocortin fragments stimulate aldosterone production by human adrenal cells in vitro. Steroids 1998; 63(9): 459-463
Education & Fellowships
| Medical School: | University College Dublin (National University of Ireland), Dublin, Ireland |
|
| Internship: | Saint Vincent's University Hospital, Internal Medicine, Dublin 4, Ireland, Ireland |
| Residency: | James Connolly Memorial Hospital, Rheumatology & Internal Medicine, Ir |
| Residency: | Mater Misericordiae University Hospital, Dublin, Ireland |
| Residency: | Limerick Regional Hospital, Internal Medicine/Endocrinology and diabetes |
| Residency: | Mater Misericordiae University Hospital, Internal Medicine, Dublin, Ireland |
| Fellowship: | Cleveland Clinic, Vasculitis, Cleveland, OH |
| Fellowship: | Royal College of Physicians of Ireland, Rheumatology Specialist Registrar Program, Ireland |
| Other Education: | (Research Fellowship) Cleveland Clinic, Cleveland, OH |
Certifications
Royal College of Physicians of Ireland - Internal Medicine
Royal College of Surgeons of Ireland
Specialty Interests
Clinical immunology, crystal arthritis. hypogammaglobulinemia, Lupus, systemic autoimmune diseases, Vasculitis.
Professional Memberships
Clinical Immunology Society
Specializes in Diseases and Conditions
Industry Relationships
Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 11/3/2008, Dr. Molloy has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
